Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Taiping Chen Image

      Taiping Chen, Ph.D.

      Department of Epigenetics and Molecular Carcinogenesis, Division of Discovery Science

      About Dr. Taiping Chen

      Dr. Taiping Chen is a geneticist and molecular biologist who studies the functions of epigenetic mechanisms, including DNA methylation and histone modifications, in mammals.  He is particularly interested in understanding the regulation and biological roles of epigenetic modifications in developmental and pathological processes.  His contributions to the epigenetics field include the identification of novel epigenetic modifiers, functional characterization of epigenetic regulators in embryonic development, gametogenesis and cell fate determination, and elucidation of the molecular mechanisms by which epigenetic alterations contribute to human diseases, including cancer.
      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX

      Regular Member, The Graduate School of Biomedical Sciences at Houston (GSBS), Houston, TX

      Research Interests

      Epigenetic modifications, including DNA methylation and histone modifications, play crucial roles in regulating chromatin structure and gene expression. Over the last two decades, great progress has been made indentifying the enzymes and regulators responsible for adding, erasing, and interpreting epigenetic modifications. However, the biological functions of many of these epigenetic "writers, erasers, and readers" remain poorly understood. Work in the Chen Laboratory aims to unraveling epigenetic mechanisms in health and disease. Researchers in the laboratory use a variety of model systems, including genetically engineered mice, embryonic stem (ES) cells, and other cell lines, to investigate the roles of epigenetic modifiers and regulators in various biological processes, including embryogenesis, gametogenesis, immunity, stem cell functions, and tumorigenesis. Currently, we are actively pursuing the following projects:

      1. The roles of histone modifications and DNA methylation, as well as their interplay, during embryonic development and gametogenesis.
      2. The roles of arginine methylation and PRMTs in mammalian development and cancer.
      3. The molecular mechanisms by which mutations in DNMT3B, ZBTB24, CDCA7 and HELLS lead to ICF (Immunodeficiency, Centromeric instability, and Facial anomalies) syndrome.

      Education & Training

      Degree-Granting Education

      2000McGill University, Montreal, CA, Ph.D. in Molecular and Cell Biology. Research: Characterization of the GSG-domain RNA-binding proteins
      1996The University of Texas at El Paso, El Paso, Texas, US, M.S. in Biology. Research: Purification and characterization of proteases from snake venoms
      1988Xi'an Medical University, Xi'an, CN, MD

      Postgraduate Training

      2000-2003Postdoctoral Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2011 - 2017

      Investigator & Laboratory Head, Novartis Institutes for Biomedical Research, Cambridge, MA, 2004 - 2011

      Physician, First Teaching Hospital, Xi’an Medical University, Xi'an, 1988 - 1993

      Other Professional Positions

      Member, Postdoc Committee, Novartis Institute for Biomedical Research, Cambridge, MA, 2006 - 2011

      Intramural Institutional Committee Activities

      Reviewer, MDACC Nominations for Endowed Fellowship Awards, The University of Texas MD Anderson Cancer Center, 2017

      Reviewer, MDACC CCSG Technology Development Grants, The University of Texas MD Anderson Cancer Center, 2017

      Reviewer, MDACC INTEREST Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Reviewer, CPRIT HIHR Proposals (MDACC Internal Review), The University of Texas MD Anderson Cancer Center, 2016 - Present

      Reviewer, Keck Family Foundation Proposals (MDACC internal review), The University of Texas MD Anderson Cancer Center, 2016

      Member, Steering Committee, EMC Program, GSBS, The University of Texas MD Anderson Cancer Center, 2015 - 2018

      Member, EMC Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2015

      Member, Organizing Committee for G&D-EMC Joint Retreat, The University of Texas MD Anderson Cancer Center, 2014

      Member, Faculty Academic Review Committee (FARC), The University of Texas MD Anderson Cancer Center, 2014

      Member, IRG-Basic Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, EMC Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013

      Member, Organizing Committee for EMC Graduate Student Retreat, The University of Texas MD Anderson Cancer Center, 2012

      Extramural Institutional Committee Activities

      Member, IBC Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Steering Committee, Genetics and Epigenetics Program, GSBS, The University of Texas MD Anderson Cancer Center, 2017 - 2018

      Member, GSBS Admissions Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018

      Member, EMC Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2016

      Member, GSBS Curriculum Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2019

      Member, Admissions Subcommittee, EMC Program, GSBS, The University of Texas MD Anderson Cancer Center, 2015 - 2018

      Editorial Activities

      Guest editor, Front Cell Dev Biol, 2021

      Guest editor, Cancers, 2013

      Editor/Service on Editorial Board(s), Epigenetic Regulators Section, Targeted Proteins Database, 2007

      Honors & Awards

      2011 - 2016CPRIT Rising Star Award, Cancer Prevention and Research Institute of Texas
      2007Catalyst Award, Novartis Institutes for Biomedical Research
      2005SPOT Award, Novartis Institutes for Biomedical Research
      2001 - 2003Long-term Fellowship, Human Frontier Science Program
      2000 - 2001Postdoctoral Fellowship, Canadian Institutes of Health Research
      2000Dean's Honor List, McGill University
      2000Postdoctoral Fellowship, National Cancer Institute of Canada
      1998 - 2000Doctoral Research Award, Medical Research Council of Canada
      1998Terry Fox Studentship, National Cancer Institute of Canada
      1997 - 1998CRS Studentship, Cancer Research Society Inc. Canada
      1997Canderal Studentship, McGill University

      Professional Memberships

      The American Society for Biochemistry and Molecular Biology (ASBMB)

      2018 - Present

      Grant & Contract Support

      Date: 2025 - 2027
      Title:Role of NLRP5 in Epigenetic Reprogramming During Early Embryogenesis
      Funding Source:NIH
      Role:PI
      ID:R21HD118141-01A1
      Date: 2025 - 2027
      Title:Role of NLRP5 in Epigenetic Reprogramming During Early Embryogenesis
      Funding Source:NIH
      Role:PI
      ID:GRANT14180818
      Date: 2024 - 2026
      Title:Defining mechanisms of cigarette smoking-induced TKI resistance in Ph+ ALL
      Funding Source:NIH
      Role:Co-I
      ID:TBD
      Date: 2023 - 2025
      Title:Preclinical studies of non-nucleoside DNMT3A/3B inhibitors
      Funding Source:NIH/NCI
      Role:PD/PI
      ID:R21CA277152
      Date: 2023 - 2026
      Title:Targeting PRMT5 in MTAP-loss melanoma
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:Principal Investigator-MDACC
      ID:ME220215
      Date: 2023 - 2027
      Title:Role of PRMT7 in Genomic Imprinting
      Funding Source:NIH/NICHD
      Role:PI
      ID:R01HD112473
      Date: 2023 - 2024
      Title:Developing non-nucleoside DNMT3A/3B inhibitors
      Funding Source:Coriell Institute for Medical Research, Epigenetics SPORE
      Role:Co-I
      ID:N/A
      Date: 2023 - 2028
      Title:Epigenome-wide study of circulating DNA methylation of HPV-associated oropharyngeal cancer and outcomes
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2027
      Title:REST-SETDB1 in DIPG
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      Date: 2023 - 2023
      Title:Explore the therapeutic effects of targeting the DNMT1-TRIM28 axis in lung cancer
      Funding Source:Internal, DRP Lung Cancer Translational Research
      Role:Co-I
      Date: 2022 - 2022
      Title:Roles of Hic2 in the Regulation of Arginine Citrullination and Neutrophil Development and Function
      Funding Source:Adverse Incident Bridge Funding, MDACC
      Role:PI
      Date: 2021 - 2026
      Title:Setdb1 in muscle stem cell maintenance and functions
      Funding Source:NIH/NIAMS
      Role:PI
      ID:R01AR077571
      Date: 2020 - 2023
      Title:Setdb1 in Muscle Stem Cell Maintenance and Functions
      Funding Source:Cockrell Endowment
      Role:PI
      Date: 2020 - 2022
      Title:Investigate the Role of DNMT3A R882H Mutant Protein in the Maintenance of AML
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:PI
      ID:UTMDACC Moon Shots Program
      Date: 2020 - 2025
      Title:Setdb1 in muscle stem cell maintenance and functions
      Funding Source:NIH
      Role:PI
      ID:GRANT12944091 R01
      Date: 2020 - 2022
      Title:Mechanism involved in maintaining DNA methylation at hemi-hydroxymethylated CpG sites
      Funding Source:NIH/NICHD
      Role:PI
      ID:R21HD100844
      Date: 2020 - 2024
      Title:Epigenetic regulation of thrombopoiesis
      Funding Source:NIH/NHLBI
      Role:Co-PI
      ID:R01HL149751
      Date: 2019 - 2021
      Title:Mechanism involved in maintaining DNA methylation at hemi-hydroxymethylated CpG sites
      Funding Source:NIH/NICHD
      Role:PI
      ID:GRANT12790058 R21
      Date: 2019 - 2022
      Title:Mechanisms Involved in Tobacco-Related DNA Methylation Changes
      Funding Source:UTMDACC
      Role:PI
      ID:Tobacco Pilot Award
      Date: 2018 - 2020
      Title:Systematic identification of DNA methylation regulators by CRISPR screening
      Funding Source:NIH/NICHD
      Role:PI
      ID:1R21HD097404-01
      Date: 2016 - 2022
      Title:Modeling ICF syndrome in mice: Role of Zbtb24 in DNA methylation and antibody production
      Funding Source:NIH/NIAID
      Role:PI
      ID:1R01AI121403-01
      Date: 2016 - 2016
      Title:Genetic studies of LSD1 functions in adult mice
      Funding Source:China Novartis Institute for Biomedical Research Co., Ltd
      Role:PI
      Date: 2015 - 2021
      Title:Role of histone H3K9 methyltransferase Eset in intestinal stem cells
      Funding Source:NIH/NIDDK
      Role:PI
      ID:IP#15020054
      Date: 2014 - 2019
      Title:A mouse model of DNMT3A-associated hematologic malignancy
      Funding Source:NIH/NCI
      Role:Co-I
      ID:S/C R01
      Date: 2014 - 2019
      Title:DNA Methyltransferases in Maintenance of Stem Cell Pluripotency
      Funding Source:Baylor College of Medicine/NIH
      Role:Co-I
      ID:S/C R01
      Date: 2013 - 2018
      Title:Epigenetic inheritance in chronic alcohol-induced transgenerational effects
      Funding Source:UTHSC-San Antonio/NIH
      Role:Co-I
      ID:S/C R01
      Date: 2013 - 2018
      Title:Mechanisms regulating self-renewal and differentiation of pluripotent stem cells
      Funding Source:Baylor College of Medicine/NIH
      Role:Co-PI
      ID:S/C P01
      Date: 2011 - 2016
      Title:Rising Star Award
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:R1108

      Selected Publications

      Peer-Reviewed Articles

      1. Liu, B, Nayvelt, K, Hardikar, S, Kondo, K, Estecio, MR, Cheng, X, Chen, T. Functional characterization of UHRF1 variants in facilitating DNA methylation. Journal of Biological Chemistry 302(7), 2026. e-Pub 2026. PMID: 42140430.
      2. Kaur, G, Ren, R, Lee, J, Horton, JR, Zhang, X, Gao, Y, Chen, T, Cheng, X. Structure of human lymphoid-specific helicase HELLS in its autoinhibited state. Nucleic acids research 54(6), 2026. e-Pub 2026. PMID: 41954988.
      3. Bocker, MT, Fanourgakis, G, Wetzel, K, Komarov, PA, Royo, H, Rohmer, A, Chun, S, Liang, CY, Kohler, H, Chen, T, Mao, X, Labow, M, Valdez, RA, Stadler, MB, de Rooij, DG, Capodieci, P, Tallarico, J, Peters, AH, Nicholson, TB. The histone H3 lysine 36 demethylase KDM2A/FBXL11 controls Polycomb-mediated gene repression and germ cell development in male mice. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40701999.
      4. Gao, G, Dornelas Moreira, J, Das, P, Lin, H, Ge, K, Chen, T, Lu, Y, Albuquerque Almeida Santos, M. Histone lysine methyltransferases MLL3 and MLL4 direct gene expression to produce platelets efficiently. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40593910.
      5. Chen, Q, Hardikar, S, Kondo, K, Dai, N, Corrêa, IR, Yu, M, Estecio, MR, Zhang, X, Chen, T, Cheng, X. GSK-3484862, a DNMT1 degrader, promotes DNMT3B expression in lung cancer cells. NAR Cancer 7(2), 2025. e-Pub 2025. PMID: 40433167.
      6. Guo, D, Du, Z, Liu, Y, Lin, M, Lu, Y, Hardikar, S, Xue, Y, Zhang, J, Chen, T, Dan, J. The ZBTB24-CDCA7-HELLS axis suppresses the totipotent 2C-like reprogramming by maintaining Dux methylation and repression. Nucleic acids research 53(7), 2025. e-Pub 2025. PMID: 40226918.
      7. Lyu Y, Kim SJ, Humphrey ES, Nayak R, Guan Y, Liang Q, Kim KH, Tan Y, Dou J, Sun H, Song X, Nagarajan P, Gerner-Mauro KN, Jin K, Liu V, Hassan RH, Johnson ML, Deliu LP, You Y, Sharma A, Pasolli HA, Lu Y, Zhang J, Mohanty V, Chen K, Yang YJ, Chen T, Ge Y. Stem cell activity-coupled suppression of endogenous retrovirus governs adult tissue regeneration. Cell S0092-8674(24), 2024. e-Pub 2024. PMID: 39476839.
      8. Shen, L, Ma, X, Wang, Y, Wang, Z, Zhang, Y, Pham, HH, Tao, X, Cui, Y, Wei, J, Lin, D, Abeywanada, T, Hardikar, S, Halabelian, L, Smith, N, Chen, T, Barsyte-Lovejoy, D, Qiu, S, Xing, Y, Yang, Y. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing. Nat Commun 15(1), 2024. e-Pub 2024. PMID: 38561334.
      9. Zhou J, Chen Q, Ren R, Yang J, Liu B, Horton JR, Chang C, Liu C, Maksoud L, Yong Y, Rotili D, Jain AK, Zhang X, Blumenthal RM, Chen T, Gao Y, Valente S, Mai A, Cheng X. Quinoline-based compounds can inhibit diverse enzymes that act on DNA. Cell Chem Biol S2451-9456(24):00403-3, 2024. e-Pub 2024. PMID: 39437789.
      10. Chen S, Hou J, Jaffery R, Guerrero A, Fu R, Shi L, Zheng N, Bohat R, Egan NA, Yu C, Sharif S, Lu Y, He W, Wang S, Gjuka D, Stone EM, Shah PA, Ahnert JR, Chen T, Liu X, Bedford MT, Xu H, Peng W. MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer 12(9):e009600, 2024. e-Pub 2024. PMID: 39313308.
      11. Du Z, Lin M, Li Q, Guo D, Xue Y, Liu W, Shi H, Chen T, Dan J. The totipotent 2C-like state safeguards genomic stability of mouse embryonic stem cells. J Cell Physiol 239(9):e31337, 2024. e-Pub 2024. PMID: 38860420.
      12. Hardikar S, Ren R, Ying Z, Zhou J, Horton JR, Bramble MD, Liu B, Lu Y, Liu B, Coletta LD, Shen J, Dan J, Zhang X, Cheng X, Chen T. The ICF syndrome protein CDCA7 harbors a unique DNA binding domain that recognizes a CpG dyad in the context of a non-B DNA. Sci Adv 10(34):eadr0036, 2024. e-Pub 2024. PMID: 39178265.
      13. Ying Z, Hardikar S, Plummer JB, Hamidi T, Liu B, Chen Y, Shen J, Mu Y, McBride KM, Chen T. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24. Cell Mol Immunol 20(12):1487-1498, 2023. e-Pub 2023. PMID: 37990035.
      14. Chen Q, Liu B, Zeng Y, Hwang JW, Dai N, Corrêa IR, Estecio MR, Zhang X, Santos MA, Chen T, Cheng X. GSK-3484862 targets DNMT1 for degradation in cells. NAR Cancer 5(2):zcad022, 2023. e-Pub 2023. PMID: 37206360.
      15. Srour N, Villarreal OD, Hardikar S, Yu Z, Preston S, Miller WH, Szewczyk MM, Barsyte-Lovejoy D, Xu H, Chen T, Del Rincón SV, Richard S. PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade. Cell Rep 38(13):110582, 2022. e-Pub 2022. PMID: 35354055.
      16. DiNardo CD, Beird HC, Estecio M, Hardikar S, Takahashi K, Bannon SA, Borthakur G, Jabbour E, Gumbs C, Khoury JD, Routbort M, Gong T, Kondo K, Kantarjian H, Garcia-Manero G, Chen T, Futreal PA. Germline DNMT3A mutation in familial acute myeloid leukaemia. Epigenetics 16(5):1-10, 2021. e-Pub 2021. PMID: 32856987.
      17. Cheng EC, Hsieh CL, Liu N, Wang J, Zhong M, Chen T, Li E, Lin H. The Essential Function of SETDB1 in Homologous Chromosome Pairing and Synapsis during Meiosis. Cell Rep 34(1):108575, 2021. e-Pub 2021. PMID: 33406415.
      18. Norvil AB, AlAbdi L, Liu B, Tu YH, Forstoffer NE, Michie AR, Chen T, Gowher H. The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme. Nucleic Acids Res 48(7):3761-3775, 2020. e-Pub 2020. PMID: 32123902.
      19. Hardikar S, Ying Z, Zeng Y, Zhao H, Liu B, Veland N, McBride K, Cheng X, Chen T. The ZBTB24-CDCA7 axis regulates HELLS enrichment at centromeric satellite repeats to facilitate DNA methylation. Protein Cell 11(3):214-218, 2020. e-Pub 2020. PMID: 31970665.
      20. Zeng Y, Ren R, Kaur G, Hardikar S, Ying Z, Babcock L, Gupta E, Zhang X, Chen T, Cheng X. The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation. Genes Dev 34(21-22):1546-58, 2020. e-Pub 2020. PMID: 33004415.
      21. Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter C, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 10(1):5494, 2019. e-Pub 2019. PMID: 31792211.
      22. He W, Zhang L, Villarreal OD, Fu R, Bedford E, Dou J, Patel AY, Bedford MT, Shi X, Chen T, Bartholomew B, Xu H. De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens. Nat Commun 10(1):4541, 2019. e-Pub 2019. PMID: 31586052.
      23. Ren R, Hardikar S, Horton JR, Lu Y, Zeng Y, Singh AK, Lin K, Coletta LD, Shen J, Lin Kong CS, Hashimoto H, Zhang X, Chen T, Cheng X. Structural basis of specific DNA binding by the transcription factor ZBTB24. Nucleic Acids Res 47(16):8388-8398, 2019. e-Pub 2019. PMID: 31226215.
      24. Chao HP, Chen Y, Takata Y, Tomida MW, Lin K, Kirk JS, Simper MS, Mikulec CD, Rundhaug JE, Fischer SM, Chen T, Tang DG, Lu Y, Shen J. Systematic evaluation of RNA-Seq preparation protocol performance. BMC Genomics 20(1):571, 2019. e-Pub 2019. PMID: 31296163.
      25. Takase R, Hino S, Nagaoka K, Anan K, Kohrogi K, Araki H, Hino Y, Sakamoto A, Nicholson TB, Chen T, Nakao M. Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation. FASEB J 33(4):5300-5311, 2019. e-Pub 2019. PMID: 30681884.
      26. Veland N, Lu Y, Hardikar S, Gaddis S, Zeng Y, Liu B, Estecio MR, Takata Y, Lin K, Tomida MW, Shen J, Saha D, Gowher H, Zhao H, Chen T. DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells. Nucleic Acids Res 47(1):152-167, 2019. e-Pub 2019. PMID: 30321403.
      27. Hamidi T, Singh AK, Veland N, Vemulapalli V, Chen J, Hardikar S, Bao J, Fry CJ, Yang V, Lee KA, Guo A, Arrowsmith CH, Bedford MT, Chen T. Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9. J Biol Chem 293(33):12770-12780, 2018. e-Pub 2018. PMID: 29959229.
      28. Gu T, Lin X, Cullen SM, Luo M, Jeong M, Estecio M, Shen J, Hardikar S, Sun D, Su J, Rux D, Guzman A, Lee M, Qi LS, Chen JJ, Kyba M, Huang Y, Chen T, Li W, Goodell MA. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome Biol 19(1):88, 2018. e-Pub 2018. PMID: 30001199.
      29. Bao J, Perez CJ, Kim J, Zhang H, Murphy CJ, Hamidi T, Jaubert J, Platt CD, Chou J, Deng M, Zhou MH, Huang Y, Gaitán-Peñas H, Guénet JL, Lin K, Lu Y, Chen T, Bedford MT, Dent SY, Richburg JH, Estévez R, Pan HL, Geha RS, Shi Q, Benavides F. Deficient LRRC8A-dependent volume-regulated anion channel activity is associated with male infertility in mice. JCI Insight 3(16), 2018. e-Pub 2018. PMID: 30135305.
      30. Veland N, Hardikar S, Zhong Y, Gayatri S, Dan J, Strahl BD, Rothbart SB, Bedford MT, Chen T. The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer. Cell Rep 21(12):3390-3397, 2017. e-Pub 2017. PMID: 29262320.
      31. Jeziorska DM, Murray RJS, De Gobbi M, Gaentzsch R, Garrick D, Ayyub H, Chen T, Li E, Telenius J, Lynch M, Graham B, Smith AJH, Lund JN, Hughes JR, Higgs DR, Tufarelli C. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease. Proc Natl Acad Sci U S A 114(36):E7526-E7535, 2017. e-Pub 2017. PMID: 28827334.
      32. Dan J, Rousseau P, Hardikar S, Veland N, Wong J, Autexier C, Chen T. Zscan4 Inhibits Maintenance DNA Methylation to Facilitate Telomere Elongation in Mouse Embryonic Stem Cells. Cell Rep 20(8):1936-1949, 2017. e-Pub 2017. PMID: 28834755.
      33. Quek K, Li J, Estecio M, Zhang J, Fujimoto J, Roarty E, Little L, Chow CW, Song X, Behrens C, Chen T, William WN, Swisher S, Heymach J, Wistuba I, Zhang J, Futreal A, Zhang J. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas. Oncotarget 8(13):21994-22002, 2017. e-Pub 2017. PMID: 28423542.
      34. Espejo AB, Gao G, Black K, Gayatri S, Veland N, Kim J, Chen T, Sudol M, Walker C, Bedford MT. PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch. J Biol Chem 292(6):2255-2265, 2017. e-Pub 2017. PMID: 28031468.
      35. Gahurova L, Tomizawa SI, Smallwood SA, Stewart-Morgan KR, Saadeh H, Kim J, Andrews SR, Chen T, Kelsey G. Transcription and chromatin determinants of de novo DNA methylation timing in oocytes. Epigenetics Chromatin 10(1):25, 2017. e-Pub 2017. PMID: 28507606.
      36. Chen Y, Kim J, Zhang R, Yang X, Zhang Y, Fang J, Chen Z, Teng L, Chen X, Ge H, Atadja P, Li E, Chen T, Qi W. Histone Demethylase LSD1 Promotes Adipocyte Differentiation through Repressing Wnt Signaling. Cell Chem Biol 23(10):1228-1240, 2016. e-Pub 2016. PMID: 27642069.
      37. Kim J, Zhao H, Dan J, Kim S, Hardikar S, Hollowell D, Lin K, Lu Y, Takata Y, Shen J, Chen T. Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse. PLoS Genet 12(4):e1005970, 2016. e-Pub 2016. PMID: 27070551.
      38. Blanc RS, Vogel G, Chen T, Crist C, Richard S. PRMT7 preserves satellite cell regenerative capacity. Cell Rep 14(6):1528-39, 2016. e-Pub 2016. PMID: 26854227.
      39. Jia Y, Li P, Fang L, Zhu H, Xu L, Cheng H, Zhang J, Li F, Feng Y, Li Y, Li J, Wang R, Du JX, Li J, Chen T, Ji H, Han J, Yu W, Wu Q, Wong J. Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer. Cell Discov 2, 16007; doi:10.1038/celldisc.2016.7:16007, 2016. e-Pub 2016. PMID: 27462454.
      40. Stewart KR, Veselovska L, Kim J, Huang J, Saadeh H, Tomizawa S, Smallwood SA, Chen T, Kelsey G. Dynamic changes in histone modifications precede de novo DNA methylation in oocytes. Genes Dev 29(23):2449-62, 2015. e-Pub 2015. PMID: 26584620.
      41. Fei Q, Yang X, Jiang H, Wang Q, Yu Y, Yu Y, Yi W, Zhou S, Chen T, Lu C, Atadja P, Liu XS, Li E, Zhang Y, Shou J. SETDB1 modulates PRC2 activity at developmental genes independently of H3K9 trimethylation in mouse ES cells. Genome Res 25(9):1325-35, 2015. e-Pub 2015. PMID: 26160163.
      42. Martin FJ, Xu Y, Lohmann F, Ciccone DN, Nicholson TB, Loureiro JJ, Chen T, Huang Q. KMT1E mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development. Genes Immun 16(2):162-9, 2015. e-Pub 2015. PMID: 25569264.
      43. Kim J, Singh AK, Takata Y, Lin K, Shen J, Lu Y, Kerenyi MA, Orkin SH, Chen T. LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice. Nat Commun 6:10116, 2015. e-Pub 2015. PMID: 26626423.
      44. Kim SJ, Zhao H, Hardikar S, Singh AK, Goodell MA, Chen T. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122(25):4086-9, 2013. e-Pub 2013. PMID: 24167195.
      45. Nicholson TB, Singh AK, Su H, Hevi S, Wang J, Bajko J, Li M, Valdez R, Goetschkes M, Capodieci P, Loureiro J, Cheng X, Li E, Kinzel B, Labow M, Chen T. A hypomorphic lsd1 allele results in heart development defects in mice. PLoS One 8(4):e60913, 2013. e-Pub 2013. PMID: 23637775.
      46. Saferali A, Moussette S, Chan D, Trasler J, Chen T, Rozen R, Naumova AK. DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line. Genome 55(9):673-82, 2012. e-Pub 2012. PMID: 22967183.
      47. Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM, Chen T, Ooi SS, Kim SY, Bestor TH, Shioda T, Park PJ, Hochedlinger K. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 44(4):398-405, S1-2, 2012. e-Pub 2012. PMID: 22387999.
      48. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, Min J, Nicholson T, Chen T, Xu G, Shi Y, Zhang K, Shi YG. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42(4):451-64, 2011. e-Pub 2011. PMID: 21514197.
      49. Nguyen AT, Xiao B, Neppl RL, Kallin EM, Li J, Chen T, Wang DZ, Xiao X, Zhang Y. DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev 25(3):263-74, 2011. e-Pub 2011. PMID: 21289070.
      50. Cho HS, Suzuki T, Dohmae N, Hayami S, Unoki M, Yoshimatsu M, Toyokawa G, Takawa M, Chen T, Kurash JK, Field HI, Ponder BA, Nakamura Y, Hamamoto R. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res 71(3):655-60, 2011. e-Pub 2011. PMID: 21115810.
      51. Singh P, Han L, Rivas GE, Lee DH, Nicholson TB, Larson GP, Chen T, Szabó PE. Allele-specific H3K79 Di- versus trimethylation distinguishes opposite parental alleles at imprinted regions. Mol Cell Biol 30(11):2693-707, 2010. e-Pub 2010. PMID: 20351169.
      52. Lohmann F, Loureiro J, Su H, Fang Q, Lei H, Lewis T, Yang Y, Labow M, Li E, Chen T, Kadam S. KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. Stem Cells 28(2):201-12, 2010. e-Pub 2010. PMID: 20014010.
      53. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461(7262):415-8, 2009. e-Pub 2009. PMID: 19727073.
      54. Yu Z, Chen T, Hébert J, Li E, Richard S. A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29(11):2982-96, 2009. e-Pub 2009. PMID: 19289494.
      55. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H, Xu G, Gaudet F, Li E, Chen T. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 41(1):125-9, 2009. e-Pub 2009. PMID: 19098913.
      56. Hu YG, Hirasawa R, Hu JL, Hata K, Li CL, Jin Y, Chen T, Li E, Rigolet M, Viegas-Péquignot E, Sasaki H, Xu GL. Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development. Hum Mol Genet 17(17):2654-64, 2008. e-Pub 2008. PMID: 18544626.
      57. Benetti, R, Gonzalo, S, Jaco, I, Muñoz, P, Gonzalez, S, Schoeftner, S, Murchison, EP, Andl, T, Chen, T, Klatt, P, Li, E, Serrano, M, Millar, SE, Hannon, GJ, Blasco, M. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 15(3):268-279, 2008. e-Pub 2008. PMID: 18311151.
      58. Schmid RS, Tsujimoto N, Qu Q, Lei H, Li E, Chen T, Blaustein CS. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome. Neuroreport 19(4):393-8, 2008. e-Pub 2008. PMID: 18287934.
      59. Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S, Baltus GA, Kadam S, Zhai H, Valdez R, Gonzalo S, Zhang Y, Li E, Chen T. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 4(9):e1000190, 2008. e-Pub 2008. PMID: 18787701.
      60. Li JY, Pu MT, Hirasawa R, Li BZ, Huang YN, Zeng R, Jing NH, Chen T, Li E, Sasaki H, Xu GL. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol 27(24):8748-59, 2007. e-Pub 2007. PMID: 17938196.
      61. Chen T, Hevi S, Gay F, Tsujimoto N, He T, Zhang B, Ueda Y, Li E. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 39(3):391-6, 2007. e-Pub 2007. PMID: 17322882.
      62. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8(4):416-24, 2006. e-Pub 2006. PMID: 16565708.
      63. Ueda Y, Okano M, Williams C, Chen T, Georgopoulos K, Li E. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development (Cambridge) 133(6):1183-92, 2006. e-Pub 2006. PMID: 16501171.

      Invited Articles

      1. Zeng Y, Chen T. DNA Methylation Reprogramming during Mammalian Development. Genes (Basel) 10(4), 2019. e-Pub 2019. PMID: 30934924.
      2. Hamidi T, Singh AK, Chen T. Genetic alterations of DNA methylation machinery in human diseases. Epigenomics 7(2):247-65, 2015. e-Pub 2015. PMID: 25942534.
      3. He XJ, Chen T, Zhu JK. Regulation and function of DNA methylation in plants and animals. Cell Res 21(3):442-65, 2011. e-Pub 2011. PMID: 21321601.
      4. Nicholson TB, Chen T, Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res 60(6):466-74, 2009. e-Pub 2009. PMID: 19643181.
      5. Ciccone DN, Chen T. Histone lysine methylation in genomic imprinting. Epigenetics 4(4):216-20, 2009. e-Pub 2009. PMID: 19483465.
      6. Nicholson TB, Chen T. LSD1 demethylates histone and non-histone proteins. Epigenetics 4(3):129-32, 2009. e-Pub 2009. PMID: 19395867.

      Review Articles

      1. Xiao Z, He R, Zhao Z, Chen T, Ying Z. Dysregulation of epigenetic modifications in inborn errors of immunity. Epigenomics 16(19-20):1301-1313, 2024. e-Pub 2024. PMID: 39404224.
      2. Dan J, Du Z, Zhang J, Chen T. The interplay between H3K36 methylation and DNA methylation in cancer. Cancer Biol Med 20(8):545-52, 2023. e-Pub 2023. PMID: 37602556.
      3. Dan J, Chen T. Genetic Studies on Mammalian DNA Methyltransferases. Adv Exp Med Biol 1389:111-136, 2022. e-Pub 2022. PMID: 36350508.
      4. Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 15(2):93-106, 2014. e-Pub 2014. PMID: 24366184.
      5. Zhao H, Chen T. Tet family of 5-methylcytosine dioxygenases in mammalian development. J Hum Genet 58(7):421-7, 2013. e-Pub 2013. PMID: 23719188.
      6. Chen T. Mechanistic and functional links between histone methylation and DNA methylation. Prog Mol Biol Transl Sci 101:335-48, 2011. e-Pub 2011. PMID: 21507357.
      7. Chen, T, Li, E. Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol 301:179-201, 2006. e-Pub 2006. PMID: 16570848.

      Other Articles

      1. Shechter, D, Huang, R, Shah, P, Dubois, T, Li, XM, Parhitko, A, Bedford, MT, Kuang, S, Chen, T, Yang, Y, Rajyaguru, P, Barsyte-Lovejoy, D, Zhao, X, Xu, W, Davies, CC, Tikhanovich, I, Tran, NT, Kako, K, Hashimoto, M, Luo, M, Hevel, JM, Fukamizu, A, Yu, MC Meeting report on FASEB protein arginine methylation. Journal of Biological Chemistry 302(6), 2026. PMID: 41967639.
      2. Zhou, J, Chen, T, Cheng, X One form and two functions. Structure 32(3):258-260, 2024. PMID: 38458157.

      Book Chapters

      1. Dan, J, Chen, T. Writers, erasers, and readers of DNA and histone methylation marks, 39-63, 2023.
      2. Ying Z, Chen T. Mechanisms of DNA methylation and demethylation during mammalian development. In: Handbook of Epigenetics. 3rd Edition. Elsevier, 11-26, 2023.
      3. Dan J, Chen T. Writers, erasers, and readers of DNA and histone methylation marks. In: Epigenetic Cancer Therapy. 2nd Edition. Academic Press, 39-63, 2023.
      4. Ying, Z, Chen, T. Mechanisms of DNA Methylation and Demethylation During Mammalian Development, 11-26, 2022.
      5. Ying, Z, Chen, T. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer, 311-328, 2018.
      6. Veland, N, Chen, T. Mechanisms of DNA methylation and demethylation during mammalian development, 11-24, 2017.
      7. Veland N, Chen T. Mechanisms of DNA methylation and demethylation during mammalian development. In: Handbook of Epigenetics. 2nd Edition. Academic Press, 11-24, 2017.
      8. Ying Z, Chen T. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer. In: Cancer and Noncoding RNAs. Elsevier, 2017.
      9. Dan J, Chen T. Genetic studies on mammalian DNA methyltransferases. In: Adv Exp Med Biol. Springer, 123-150, 2016.
      10. Nicholson, TB, Veland, N, Chen, T. Writers, Readers, and Erasers of Epigenetic Marks, 31-66, 2015.
      11. Nicholson TB, Veland N, Chen T. Writers, readers, and erasers of epigenetic marks. In: Epigenetic Cancer Therapy. Elsevier Inc, 31-66, 2015.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 12, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Taiping Chen Laboratory

      • Epigenetics and Molecular Carcinogenesis department

      • Discovery Science division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top